Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep781 | Obesity | ECE2016

Bariatric surgery: a health economic perspective of the prescription costs

Paredes Silvia , Pereira Maria Lopes , Fernandes Aline , Manso Fernando , da Costa Maia , Marques Olinda , Alves Marta

Introduction: The economic burden of obesity on healthcare systems is increasing. Bariatric surgery leads to considerable weight loss and health improvement. However, this surgery is costly and doubts about its affordability have been raised. Few studies have assessed outcomes such as drug use and costs after bariatric surgery. The aim of this study was to evaluate drug consumption and costs before and after bariatric surgery.Methods: Retrospectively, da...

ea0037ep1232 | Clinical Cases–Pituitary/Adrenal | ECE2015

Primary hyperaldosteronism by Conn's syndrome: clinical case discussion

Coelho Claudia , Monteiro Ana Margarida , Fernandes Vera , Souto Selma B , Manso Fernando , Marques Olinda

Introduction: Primary hyperaldosteronism (PA) is a disturbance caused by the autonomous production of aldosterone by the adrenal gland. The most frequent causes are due to bilateral supra-renal gland hyperplasia and aldesterone producing adenoma. It is most frequent amongst women aged between 30 and 50 years of age. It is clinically characterised by hypertension (HTN), resistant to therapy. Hypokalaemia, which is known as a ‘classical marker’ is found in less than a ...

ea0035p546 | Endocrine tumours and neoplasia | ECE2014

Pheochromocytoma and neurofibromatosis type 1: description of case

Monteiro Ana Margarida , Alves Marta , Souto Selma , Manso Fernando , Cruz Mariana , Marques Olinda

Introduction: The pheochromocytomas are rare neuroendocrine tumors that can occur sporadically or, in about 30% of cases, in the context of family syndromes. Ten percent are malignant. Neurofibromatosis type 1 is an autosomal dominant disease that is associated with the occurrence of these tumors. Pheochromocytoma appears at 0.1– 5.7% of patients with neurofibromatosis type 1, and are usually solitary and benign lesions.Clinical case: A 50-year-old ...

ea0049ep706 | Obesity | ECE2017

Folate: a new player in metabolic syndrome?

Paredes Silvia , Alves Marta , Pereira Maria Lopes , da Costa Jose Maia , Fernandes Aline , Manso Fernando , Marques Olinda , Ribeiro Laura

Introduction: Bariatric surgery (BS) candidates display several nutritional deficiencies that can aggravate after surgery. Metabolic syndrome (MS) is a cluster of cardiovascular risk factors with several disturbed metabolic pathways. Therefore, individuals with MS submitted to BS are probably more prone to nutritional deficiencies.Objective: To evaluate the prevalence of nutritional deficiencies and eventual differences between BS candidates with and wit...

ea0049ep707 | Obesity | ECE2017

Evolution of body composition 3 years after sleeve gastrectomy

Paredes Silvia , Alves Marta , Pereira Maria Lopes , da Costa Jose Maia , Fernandes Aline , Manso Fernando , Marques Olinda , Ribeiro Laura

Background: Sleeve gastrectomy (SG) has effective results on weight loss, which should result from fat mass loss and efforts should be made to preserve lean mass. Few studies have evaluated body composition (BC) changes after SG for periods >2 years.Objective: To investigate the impact of SG on weight and BC, comparing by gender.Materials and methods: Retrospectively, databases of patients who underwent SG between 2011 and 2013...

ea0056gp102 | Diabetes Therapy | ECE2018

Type 2 diabetes remission one year after bariatric surgery – a comparison between vertical sleeve gastrectomy and gastric bypass

Barros Ines Ferreira , Paredes Silvia , Manso Fernando , da Costa Jose Manuel Maia , Fernandes Aline , Alves Marta , Pereira Maria Lopes

Background: Gastric Bypass surgery (Bypass) is recognized as the ultimate metabolic surgery. The success in type 2 Diabetes (DM2) remission documented in patients submitted to Vertical Sleeve Gastrectomy (Sleeve) made questionable the hypothesis that this restrictive surgery has beneficial metabolic effects.Main goal: Comparing the Bypass and Sleeve’s efficacy in DM2 remission.Methods: Retrospective study of 112 diabetic patie...